logo-education
0370 270 6000

already registered?

Please sign in with your existing account details.

need to register?

Register to access exclusive content, sign up to receive our updates and personalise your experience on brownejacobson.com.

Privacy statement - Terms and conditions

Forgotten your password?

'for profit' schools a non-starter?

21 April 2015

If there is one education topic likely to cause debate during an election period, it’s the issue of ‘for profit’ schools. As a recent Guardian article confirms, any uncertainty about the Conservative’s position has been clarified by their manifesto – they will not introduce ‘for profit’ schools. But would ‘for profit’ schools even be viable in England?

Schools often generate profit by letting out their facilities or seconding staff. Income generated is recycled back into the school to purchase items for the benefit of students and the community.

A school which allowed surplus income to be paid out to shareholders by way of a dividend would potentially cease to be a charity and lose the tax benefits that come with charitable status. The costs of running the school would then increase significantly, making generating a profit a difficult and unattractive option for investors.

The concept may well be a non-starter for political parties and commercial sponsors alike.

Related opinions

Does the move into Step 4 mean the ending of Covid-19 restrictions within schools?

With the Prime Ministers announcement that he intends for Step 4 to begin on 19 July, this will also bring an end to the restrictions currently in place on education settings.

View blog

Advocacy in Action: Female Genital Mutilation Protection Orders (FGMPO)

The issue of Female Genital Mutilation Protection Orders and the importance of education providers to act promptly.

View blog

Responsibilities towards students identifying as non-binary

Our top tips for supporting transgender and non-binary pupils.

View blog

Schools face scrutiny over Covid-19 vaccinations for children

On 4 June, the Medicines and Healthcare products Regulatory Agency (MHRA) approved the use of the Pfizer/BioNTech Covid-19 vaccine for 12- to 15-year-olds.

View blog

Mailing list sign up

Select which mailings you would like to receive from us.

Sign up